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Abstract  
Ion sources are key components of accelerators devoted to different types of 
medical applications: hadron-therapy facilities (accelerating protons or carbon 
ions), high-intensity accelerators for boron-neutron capture therapy (using 
intense proton beams), and facilities for isotope production (using different 
ion species). The three types of application present different requirements in 
terms of ion beam quality, reproducibility, and beam availability. Different 
characteristics of ion sources will be described, along with the reasons why 
they are particularly interesting or largely used.  
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1 Introduction  
For medical facilities, ion-source design must be oriented according to the needs of three demanding 
applications:  
– hadron-therapy facilities (accelerating protons or carbon ions);  
– BNCT (boron-neutron capture therapy, accelerating protons); 
– isotope production (producing different ion species). 
The requirements for an ion source devoted to medical applications are not unequivocally determined. 
High currents are required (between hundreds of µA and tens of mA), but there are more stringent 
constraints than the one on beam intensity. The characteristics for ion sources devoted to these purposes 
can be summarized as follows: 
a) ability to produce the necessary beam current for the treatment (with a contingency margin of 
20% or more), i.e. 200–400 eµA for carbon ions and three-times more for protons (up to tens of 
mA of protons in the case of BNCT facilities); 
b) beam emittance lower than accelerator acceptance, typically 0.5-0.7 𝜋𝜋 mm mrad normalized; 
c) high stability, low beam ripple, and high reproducibility; 
d) user friendly; 
e) high MTBF (mean time between failure); 
f) low maintenance. 
Requirements d)–f) are very important for all types of application, since hospital facilities need versatile 
devices with a short tuning time. 
Some sources may be adapted for different applications, i.e. a source producing multiply charged 
ions may work for hadron therapy and for isotope production, while intense beams of protons are used 
for BNCT and for isotope production. Often, in order to minimize the spare parts and the overall 
complexity, the same type of ion source is made available in two copies, in order to be interchangeable. 
Uptime is essential for medical applications, more than for ion sources devoted to nuclear-physics 
accelerators. The above-mentioned characteristics restrict the scope of possible ion sources to those 
high-current ion sources based on the formation of a dense and hot plasma. The ions are generated inside 
the plasma, and then extracted by beams of electrostatic optical elements. The production of the plasma, 
the extraction of ions from the plasma, and the beam management coincide to fulfil the requirements, 
and particular care is given to each stage to avoid the emittance growth (and poor transport of the beam 
to the users) and the beam halo formation. 
1.1 General technical characteristics 
The definition of ion-source properties is given by the mechanism of plasma formation. In a few words, 
a good knowledge of the plasma parameters simplifies the fulfilment of the requirements. Laboratory 
plasmas—including the ones generated in compact ion sources—can be produced in several manners, 
and they differ from each other in the electron temperature, electron density, and plasma lifetime. 
Electrical discharges under vacuum, electron beams passing through neutral gases or, in a more 
complicated manner, electromagnetic waves interacting with gases or vapours, in the presence of a well-
shaped magnetic field, are the mechanisms used for inducing discharges in gaseous systems, and 
producing plasmas with suitable characteristics as sources of singly charged or multi-charged ions. 
Some common features of any ion source used in research or medical laboratories are summarized here:  
– a cylindrically shaped under-vacuum cavity with metallic walls, with vapour or gas fluxed before 
turning on the plasma; 
– some flanges for gas feeding, ovens, electron beams, and other tools for plasma discharge tuning; 
– a system feeding the energy needed to the discharge (electrostatic energy, electromagnetic waves, 
etc.); 
– a system for plasma confinement (e.g. magnetic trap); 
– an ion extraction system able to optically manipulate the beam, ensuring good collimation, low 
energy spread, and low emittances. 
Other ancillary systems include pumps, control systems, and several kinds of diagnostics (for both the 
plasma and the produced beam). More information is available in [1–3]. 
Ion sources may be chosen from among a large variety, e.g.: 
1) PIG: i.e. Penning ion sources [4]; 
2) EBISs: i.e. electron beam ion sources; 
3) LISs: i.e. laser ion sources; 
4) ECRISs: i.e. electron cyclotron ion sources. 
5) H-source ‘family’: 
a) helicon sources; 
b) surface plasma sources; 
c) volume sources; 
d) RF sources. 
Sources 1)–3) in the above list are not convenient for the use in medical facilities for several 
reasons. PIG sources are unfit for medical applications due to their short lifetime. EBISs are more 
appropriate for nuclear-physics facilities requiring low currents but extremely high charge states. LIS 
produced beams are affected by high-energy spreads. Sources 4) and 5) (including all the different kinds 
of sources belonging to this ‘family’) are therefore the most used in worldwide medical facilities. The 
motivation of their use and the specifications that are particularly relevant will be hereinafter described, 
while for the operation principle of each type of ion source, we refer to [1–3]. 
2 Hadron therapy facilities 
Because of the increasing interest in different ion species and beam features, and because of the larger 
social impact of hadron therapy, a large part of this note is devoted to such ion sources. 
Hadron therapy, up to now, has used very few types of particles, thus limiting the requirements 
for ion sources to proton (even for neutron generation) and carbon beams, in most cases. Rarely, 
deuteron, helium, oxygen, neon and argon beams have been required. 
2.1 Ion sources for proton therapy 
The current rate requested for proton therapy is always in the range of 1 mA or even less, so the types 
of proton sources [1–3] used as injectors for proton-therapy accelerators are: 
– multicusp volume or surface plasma sources for H–; 
– 2.45 GHz microwave discharge ion source; 
– duoplasmatron; 
– PIG ion sources. 
Several types of H– sources are used, based on different mechanisms of plasma generation and 
beam formation. Surface plasma sources, with magnetrons, Penning ion gauge (PIG) ion sources with 
and without convertors, as well as magnetic-multipole volume sources, with and without caesium, are 
used. The methods of igniting and maintaining magnetically confined plasmas may be quite different: 
hot and cold cathodes, radio frequency and microwave power, etc. The extraction systems are 
specialized and use magnetic and electric fields to guide the beam towards the low-energy beam 
transport line, providing cw (continuous wave) beams or pulsed beams with ad hoc time structures.  
Simple commercial multicusp sources are often used to produce 1–2 mA of protons [5] while 
more complex devices are developed for larger currents. Several improvements have been implemented 
to the H– sources in the last decades; e.g. at Lawrence Berkeley National Laboratories (LBNL, USA) 
many efforts were made in developing innovative RF antennas for the optimization of RF matching to 
the plasma. In 1990, Leung et al. [6] reported the use of inductively generated plasma for producing 
H– beams ‘with almost no lifetime limitation’. The efficiency was shown to be higher than the case of a 
source with a filament. In 1993, the same group reported [7] a three-fold gain in H– beam using a collar 
with a SAES company Cs dispenser. In 1996, Saadatmand et al. [8] increased the current to 70–100 mA 
running at 10 Hz 0.1 ms with the SSC (Superconducting Super Collider) source modelled after the 
LBNL source. The H– beam appeared to be stable for up to 8 hrs. 
Additional advancements were achieved at LBNL with the SNS (Spallation Neutron Source) 
H– ion source: a caesium-enhanced, multicusp ion source [9]. For the ion extraction and transport, an 
advanced Low-Energy Beam Transport (LEBT) line was designed in order to properly manipulate the 
extracted beam. The very compact LEBT, shown in Fig. 1, was made of a two-lenses, electro-static 
system, only 12 cm long. Lens 2 was split into four quadrants to steer, chop, and blank the beam.  
 
 
Fig. 1: Sketch of the H– source with a compact LEBT [10] 
The results are good and the source is suitable with some limitations for medical accelerators: a 
30 mA peak current is produced with horizontal r.m.s. normalized emittance of 0.115 mm mrad, and, 
even when running Cs free, the H–  volume source produces 10–15 mA of H–.  
Another widely used H– source is the so-called Helicon Discharge Surface Plasma Source [10]. 
The versatility of this source, along with its ability to produce different ion species, the fairly long 
MTBF, and relatively good stability, might be applicable to different medical facilities. Figure 2 shows 
the main subsystems of these devices, including: 1–gas valve; 2–discharge volume; 3–discharge vessel; 
4–helicon saddle-like antenna; 5–magnetic coil; 6–ion/atom converter; 7–electron flux; 8–emission 
aperture (slit); 9–extraction electrode; 10–suppression /steering electrode; and 11–ground. 
 
Fig. 2: Scheme of helicon discharge surface plasma source 
The H+ sources which may be suitable for medical facilities are the 2.45GHz off-resonance 
discharge microwave ion sources (also known as microwave discharge ion sources—MDIS) [11–12]. 
They present many advantages in terms of compactness, high reliability, ability to operate in cw mode 
or in pulsed mode, reproducibility, and low maintenance. High-current proton beams may be delivered, 
up to 100 mA, with low transversal r.m.s. normalized emittance, of the order of 0.20 to 0.30 π mm mrad. 
The major advantage of MDIS comes from the absence of antennas, which makes this equipment 
reliable for long duration operations (even months) with good reproducibility. This is a condition for 
computer-controlled operations, without intervention of operators. The scheme of the source is simple 
and is shown in Fig. 3. 
 
 
Fig. 3: Original MDIS design at Chalk River National Laboratory [11]  
2.2 Ion sources for carbon therapy 
ECRISs, EBISs, and laser ion sources may be able to produce multiply charged ions, but only ECRISs 
are suitable for carbon therapy (and proton therapy as well), as they can provide beam currents of  
hundreds of microamperes with good long-term stability and reproducibility. 
The operating principle and additional information may be found in [1, 13] along with the scaling 
laws that determine the beam characteristics. Some conditions have been explored in the 1990s that 
permit a long enough plasma confinement time to be obtained and multiply charged ion beams to be 
produced. For the sake of brevity, let us say that the conditions needed to produce intense beams of C4+ 
and C6+ used in hadron therapy may be summarized by the high-B mode concept, which states that for 
a high-frequency Electron Cyclotron Resonance (ECR) source, the magnetic confinement should obey 
the rule 
B/BECR > 2. 
According to this concept, a higher B/BECR increases the electron temperature and the ion lifetime 
and fully stripped heavy ions are obtained. It does not explain the evolution of the electron temperature 
Te and its dependence on the power density in the plasma chamber (microwave coupling to plasma is 
limited by other instabilities in addition to the magnetohydrodynamical ones, which instead limit the 
ion lifetime). Moreover, the charge exchange process becomes crucial for inner-shell electrons and, even 
in presence of high production rates of highly charged ions (HCI) in the plasma, few HCI appear in the 
extracted beam if the pressure is not further improved, in the range of 10–7 mbar or better. The operating 
frequency also plays a role and the ECRISs for hadron therapy use microwave generators with 
frequencies equal to, or higher than, 10 GHz. 
The description of the ECRIS operating principles in [1, 13] does not complete the scope of 
specific requirements of ECRISs for hadron-therapy facilities. In fact, though the conditions of magnetic 
confinement, vacuum, and microwave frequency are satisfied, the result may be not sufficient for the 
full exploitation of an accelerator facility for treatment, and additional conditions must be satisfied in 
order to ensure patient safety and successful treatment. Additional interlocks on the RF system, or high 
voltage power supplies, permit the medical operator to ensure the patient’s safety, while for successful 
treatment, it is necessary to have a stable emittance figure and a beam ripple as low as possible.  
It should be also considered that ECRISs must be adapted to make them suitable for hospital 
facilities: 
– a hospital facility is not adapted to the ‘difficult case’ of multi-parameter ECR sources that can 
be managed in a laboratory environment, so the most advanced third generation ECRIS must be 
discarded [14]; 
– a ‘high-performance conventional ECRIS’ has large operating costs for electricity, which is not 
the case for a source with permanent magnets, even if its performance is worse; 
– minimizing the number of components subject to failure makes the source reliability better. 
Standard ECR ion sources have been specialized for carbon therapy. The two series most 
commonly known worldwide are the Supernanogan type and the so-called KEI series. Their main 
features are listed in Table 1. Figure 4 shows a picture of the two ion sources [15–16]. 
Table 1: Main features of commercial ion sources 
Source Supernanogan KEI series 
Type ECR ECR 
Magnets permanent  Permanent 
Ion Carbon Carbon 
Charge/current 4+/200–250 µA 4+/240–430 µA  
Extraction voltage 24 kV 30 kV 
Frequency 14.25–14.75 GHz 9.75–10.25 GHz 
Operation CW Pulse 
Gas CO2 CH4 
 
       
 
Fig. 4: (left) A Supernanogan-type ion source [15], and (right) a KEI-type source [16] 
The KEI sources are used in Japanese facilities, whilst the Supernanogan type are largely used in 
Europe, and they became a standard solution as beam injectors of hadron-therapy facilities, in spite of 
their limited beam brightness. The Supernanogan source is equipped with a double-wall, water-cooled 
plasma chamber, with a 7 mm diameter aperture for beam extraction. The permanent-magnet system 
provides the axial and radial confinement (axial field from 0.4 to 1.2 T, radial field 1.1 T), and the 
extraction system and RF injection have been optimized through the years for the maximum reliability. 
The RF injection consists in the so-called, copper-made ‘magic cube’, made of a waveguide to coaxial 
converter with a tuner to minimize the reflected power. An RF window is used for the junction between 
the magic cube at high vacuum and the waveguide at atmospheric pressure. 
The injection flange hosts also a DC bias system to add electrons to the plasma and decrease the 
plasma potential. An RF generator, of about 400 W at 14.5 GHz, is used for feeding the plasma (the 
effective power used in operation is below 300 W). In order to make a further optimization of the beam 
properties (both current and emittance) possible, flexible frequency variable travelling-wave-tube 
amplifiers (TWTAs) are used in order to exploit the so-called frequency tuning effect (FTE) [17]. The 
main beam parameters, and the improvements proposed by INFN-LNS scientists, are listed in Table 2 
(implementation of a frequency tuning device for the microwave injection; design of a new extraction 
system for further improvement of the beam emittance and beam stability; and changes to the gas input 
system in order to achieve a much better stability). 
The FTE was applied since significant improvements were observed at INFN-LNS when a source 
was fed by a klystron or a Travelling-Wave-Tube (TWT) based generator. It was then understood that 
FTE does not only change the plasma density, but it also strongly affects the beam formation dynamics. 
In Fig. 5, it is shown that a wide fluctuation of the output beam current is obtained by varying the feeding 
frequency for a C4+ ion extracted by the Supernanogan source of CNAO, Pavia. 
The impact of the wave frequency on the formation and spatial distribution of the warm electrons, 
including the effects on ion dynamics, was investigated in [18] showing that: i) the energy absorption is 
influenced by the electromagnetic field modal distribution inside the cavity, affecting the heating 
rapidity; ii) the frequency also impacts on the density distribution—warm electrons are mostly formed 
where a high field intensity exists; and iii) the RF heating near resonance induces the formation of a 
non-homogeneously distributed plasma. All this information can be exploited for our purpose, because 
the variation of the electron energy distribution fraction may optimize the production of some charge 
states while the electromagnetic mode distribution may improve the beam emittance. 
Table 2: Main beam parameters and improvement steps of the Supernanogan ion source (made with the aid of 
INFN-LNS ion-sources team). 
Ions Current 
(requested) 
[µA] 
Current 
(available) 
[µA] 
After improvements 
by INFN-LNS 
[µA] 
Emittance 
(requested) 
[π mm mrad] 
Emittance   
(measured)          
[π mm mrad] 
Stability 
[99.8%] 
C4+ 200 200 250 0.75 0.56 36 h 
H2+ 1000 1000  0.75 0.42 2 h 
H3+ 700 600 1000 0.75 0.67 8 h 
He+ 500 500  0.75 0.60 2 h 
 
 
 
Fig. 5: Experimental evidence of frequency tuning effect with the Supernanogan-type ECRIS of CNAO, around 
14 GHz [17]. 
Additional ‘alternative heating schemes’—like two-frequency heating (TFH)—have proved very 
helpful in improving the beam stability, which indeed represents a key challenge for cancer treatment 
machines. TFH consists of simultaneously launching two electromagnetic waves into the plasma, at 
different frequencies, in order to improve the plasma confinement and the overall stability. This, in turn, 
decreases the extracted beam ripple, as can be seen in Fig. 6. 
 
 
Fig. 6: Impact of TFH—two frequency heating in terms of current and beam ripple damping [19] 
Future perspectives in hadron therapy—like the production of higher carbon-ion currents and 
metallic ions as lithium or beryllium—will require more performing ECRISs.  
The AISHa (Advanced Ion Source for Hadrontherapy) project [20] will try to overcome such 
challenges. AISHa is a hybrid ECRIS: the radial confining field is obtained by means of a permanent 
magnet hexapole, while the axial field is obtained with a set of four superconducting coils. The 
superconducting system will be helium free at 4.2 K, by using two cryocoolers. The magnetic field 
values are following the scaling laws (R. Geller) and the high-B-mode concept [13–14]. The operating 
frequency of 18 GHz has been chosen to maximize the plasma density, taking into account the 
availability of commercial microwave tubes and the specificity of the installation in hospital 
environments. The electric insulation is chosen to be 40 kV, for daily operation above 30 kV. A sketch 
of the AISHa ion source is shown in Fig. 7, while the main features are listed in Table 3. 
The set of four superconducting coils independently energized will permit a flexible magnetic 
trap to be realized and the electron energy distribution function (EEDF) to be adapted to the users’ needs. 
The use of a broadband microwave generator able to provide signal with complex spectrum content, 
will permit the frequency to be tuned efficiently, increasing the electron density, and therefore, the 
performance, in terms of current and average charge state produced. 
The chamber dimensions and the injection system have been designed to optimize the microwave 
coupling to the plasma chamber, taking into account the need for space to house the oven for metallic 
ion beam production. This feature may represent a significant step above the current technology, with 
the goal of keeping a very low beam ripple, even in the presence of larger plasma density and high oven 
temperature. 
The ability of the AISHa source to operate with larger RF power may be applied to the production 
of C6+ for compact cyclotrons. In fact, the use of an accelerator chain based on a synchrotron increases 
the cost of a heavy-ion-therapy facility, but, up to now, the success of compact cyclotrons accelerating 
C6+ has been limited by the insufficient stability, reliability, and reproducibility of high-performance 
ECRISs. For example, the HEC (high-voltage extraction configuration) source developed at NIRS-
Chiba (National Institute of Radiological Sciences) is a powerful ECRIS operating at 18 GHz, and its 
performances are more than double the KEI sources, but conversely, its application in a hospital has not 
been judged as viable by the research group that developed it, because of its complexity and 
reproducibility. 
 
 
Fig. 7: Sketch of the AISHa ion source [20] 
Table 3: Main operating parameters of the AISHa source 
Parameter Value 
Radial field 1.3 T 
Axial field 2.6 T–0.4 T–1.5 T 
Operating frequencies 18 GHz (TFH) 
Operating power 1 kW 
Extraction voltage 40 kV 
Chamber diameter / length Φ 92 mm / 300 mm 
LHe Free 
Iron yoke diameter / length 42 cm / 60 cm 
Source weight estimation 480 kg 
2.3 Ion sources for BNCT 
Ideal ion sources for BNCT should fulfil the requirements of neutron-flux production via reactions 
induced by intense proton beams. The beam current (with a margin of 20% or more) should lie in the 
range of many mA of protons. Even in this case, high stability and high reproducibility are mandatory, 
along with a very high MTBF.  
Two types of ion sources are particularly suitable for BNCT facilities: multicusp sources of 
H– beams and MDIS for H+. 
A typical example is the multicusp source of Kyoto University. The source is able to provide 15 
mA of H– beams with 0.66 𝜋𝜋 mm mrad 4 r.m.s. normalized emittance [21]. The source was developed 
in 1990 for injection in a TR70 cyclotron. The first version was able to produce up to 7 mA H– beams, 
but the upgraded version (1994) allowed the source performances to improve by up to 15 mA cw at 
5 kW of arc power. 
MDIS ion sources can be useful sources for BNCT since they generate beams characterized by 
low emittance (< 0.2 π mm mrad) and beam ripple. They are able to guarantee very high MTBF due to 
their reliability. Figure 8 shows the Trasco Intense Proton Source (TRIPS), a high-intensity microwave 
source, whose goal is the injection of a maximum proton current of 35 mA in a radio-frequency 
quadrupole (RFQ), with an r.m.s.-normalized emittance lower than 0.2 π mm mrad at the operating 
voltage of 80 kV [22]. TRIPS was originally developed as a proton source for driving a subcritical 
reactor to transmute nuclear waste, but it is considered for BNCT facilities at INFN. It has been tested 
for reliability, which reached an interesting value of 99.8% over 142 h. 
 
Fig. 8: Layout of the TRIPS proton source designed and tested at INFN-LNS [22] 
2.4 Ion sources for isotope production 
Ion sources for isotope production must be characterized by beam currents as large as possible 
(depending on the limits on target reliability) and emittance lower than the accelerator acceptance. Also, 
in this case, a high MTBF is required. Commercial cyclotrons for the in-situ production of protons or 
deuterons at energies in the range 10–100 MeV, with beam currents up to 2 mA, are available.  
H– ion sources are often used, such as a multicusp ion source, or RF-driven ion sources and 
helicon sources. Other options, such as ECR-driven ion sources, have been considered but they have a 
narrow application because of the larger cost and complexity.  
It can be seen that the development of sources for isotope production is not subject to 
breakthrough but is rather the outcome of technological steps. For example, the development of the 
filament-driven surface conversion ion source regarded the filament properties. In fact, the filament 
strength and longevity depend on the material grain size, impurities, and processing. For example, 
adding 3% of rhenium into tungsten filaments has been proven to enhance the material properties in 
other applications. 
The improvement of the filament material would allow longer lifetimes at the same performance 
level or higher currents at the same lifetime. The improvement of the source temperature control permits 
higher performance, provided that the lifetime does not change significantly. Furthermore, the 
improvements in beam current allow the size of the extraction aperture to be reduced, leading to the 
decrease of the emittance. 
The feasibility of RF-driven H– ion sources has been attractive because of their longer lifetimes, 
obtained by means of an external antenna, and their larger plasma density. Furthermore, surface 
production is more effective and technologically simpler [23]. The neutral pressure seems to be the 
limiting parameter in the case of the helicon source, whilst the 2.45 GHz MDIS could be a useful kind 
of source for overcoming any limitations in future years. 
3 Conclusions 
In this presentation, I have outlined some peculiar aspects of the science and technology of ion sources, 
rather than the working principles of the different types of ion sources which cannot be described in a 
short paper; they are available in the CERN Accelerator School textbook and in other relevant textbooks 
[1–3]. More relevance was given to the comprehension of the requirements set by the different medical 
applications along with the ability to provide the needed specifications of the source over a long time 
period, with decent reproducibility in order to guarantee the satisfaction of the users, particularly 
important in the case of therapy. There is plenty of room for future improvements coming from a better 
knowledge of the basic processes and improved ability to simulate them and to forecast the produced 
beam properties. The development of better ion sources may permit the success of treatment to be 
increased, the cost to be decreased, and finally the application of accelerators to be extended to medical 
facilities as the result of increased social awareness. The optimization of performance of ion sources 
and their matching to the accelerators may improve the budget of the isotope production facilities and 
may extend the variety of isotopes with great advantages for medical diagnostics. 
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